Biotech Funding and Spinouts
Kilder
- Endpoints: Encoded closes $275M Series F for Dravet syndrome drug
- BioPharma Dive: A new immuno-oncology play raises $225M for a next-generation drug
- BioPharma Dive: Kura spins diabetes work into a Lilly-backed biotech startup - BioPharma Dive
- BioSpace: Solstice rises with $225M to develop next-gen CTLA-4 drug from China - biospace.com
- STAT: STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea
- STAT: Orexin discoverers awarded prestigious Lasker award - STAT
- BioPharma Dive: Kura spins diabetes work into a Lilly-backed biotech startup
- Pharmexec: Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes - Pharmaceutical Executive
- BioPharma Dive: A new immuno-oncology play raises $225M for a next-generation drug - BioPharma Dive
- Endpoints: Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinic
- GEN: No One-Size-Fits-All Solution for Autologous Cell Therapy Manufacturing
- GEN: Increasing CHO Cell Productivity - Genetic Engineering and Biotechnology News
- wikimedia: Photo by Ruei-Min Lu, Yu-Chyi Hwang, I-Ju Liu, Chi-Chiu Lee, Han-Zen Tsai, Hsin-Jung Li & Han-Chung Wu / Wikimedia Commons / CC BY 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.